ACR2022 - Day 1.2

2022-11-12

Download 1.7k

A Year in ReviewDr. Jack Cush, Philadelphia Differences in Clinical Presentation and Outcomes of Early vs Late Onset PsADr. Olga Petryna, New YorkAbstract 0377 mTORC1 as a Driver of Inflammation in sJIA Connecting Pathogens of sJIA and MASDr. Olga Petryna, New YorkAbstract 0004 Patient Reported Outcomes in PsA Using Novel IL 17A InhibitorDr. Sims discusses abstract 0199 presented at ACR22 Convergence in Philadelphia, PA.Abstract 0199: Izokibep, a Novel IL-17A Inhibitor, Improves Patient-reported...

A Year in Review
Dr. Jack Cush, Philadelphia

Differences in Clinical Presentation and Outcomes of Early vs Late Onset PsA
Dr. Olga Petryna, New York
Abstract 0377

mTORC1 as a Driver of Inflammation in sJIA Connecting Pathogens of sJIA and MAS
Dr. Olga Petryna, New York
Abstract 0004

Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor
Dr. Sims discusses abstract 0199 presented at ACR22 Convergence in Philadelphia, PA.
Abstract 0199: Izokibep, a Novel IL-17A Inhibitor, Improves Patient-reported Outcomes – 16-Week Results from a Placebo-controlled Phase 2 Study in Patients with Active Psoriatic Arthritis

The CONSUL Trial
Dr. Sheila Reyes, The Phillipines
Abstract 0526

Comments (3)